Rebio Health

We eliminate biofilm infections with electrochemical technology.

Operating in global overseas acceleration & learning (goal) based in JP, Rebio Health was founded in 2001.

Profile

We are developing electrochemical devices to treat biofilm infections in orthopedic implants, including joint replacements and fracture fixation hardware. Today, these infections are extremely difficult to cure due to biofilm formation, often forcing patients to undergo multiple surgeries and implant removal. Our technology targets and eradicates biofilms at the source, offering a fundamentally new approach that could reduce reoperation rates and transform the standard of care.

Rebio Health is positioned in global overseas acceleration & learning (goal), a segment that rewards a clear, focused offering.

The company is recorded as being based in JP.

Its current recorded stage is Small private company.

Website: nims.go.jp